Primary Site >> Biliary tract Cancer
Gene >> RAB3D
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma. PMID: 17589952 |
Ref: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. PMID: 20375404 Ref: Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study. PMID: 21071270 |
Ref: Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. PMID: 22782416 |
Ref: Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. PMID: 24852116 Ref: Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial. PMID: 25095718 |
Ref: Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis. PMID: 25826274 Ref: Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial PMID: 26228433 |
Ref: Novel investigational therapies for treating biliary tract carcinoma. PMID: 27771967 |
Ref: Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers. PMID: 27752787 Ref: Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications. PMID: 28405328 Ref: Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours. PMID: 28601826 Ref: Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. PMID: 28652652 Ref: Hepatic intra-arterial and systemic chemotherapy followed by maintenance therapy for the treatment of cholangiocarcinoma. PMID: 30191053 |
Ref: Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial. PMID: 28796864 Ref: Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine. PMID: 29121415 Ref: Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma. PMID: 29182496 Ref: Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study. PMID: 29325521 Ref: EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs. PMID: 29721058 Ref: Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers. PMID: 30368584 |